학술논문
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial
Document Type
Article
Author
Straus, David J ; Długosz-Danecka, Monika; Connors, Joseph M; Alekseev, Sergey; Illés, Árpád; Picardi, Marco; Lech-Maranda, Ewa; Feldman, Tatyana; Smolewski, Piotr; Savage, Kerry J; Bartlett, Nancy L; Walewski, Jan; Ramchandren, Radhakrishnan; Zinzani, Pier Luigi; Hutchings, Martin; Munoz, Javier; Lee, Hun Ju; Kim, Won Seog; Advani, Ranjana; Ansell, Stephen M; Younes, Anas; Gallamini, Andrea; Liu, Rachael; Little, Meredith; Fenton, Keenan; Fanale, Michelle; Radford, John
Source
In The Lancet Haematology June 2021 8(6):e410-e421
Subject
Language
ISSN
2352-3026